Sort   by:  
 Page size 
GenomicsGenentech_cell_line_SNP
SNP array data for 668 cancer cell lines
EGAD00010000951 | EGA
Genomicsena-DATASET-Genentech-11-09-2014-19:43:22:926-1 - samples
RNAseq and exome sequencing data of gastric cancer cell lines.
EGAD00001001013 | EGA
Genomicsena-DATASET-GENENTECH-24-01-2014-01:33:01:945-58 - samples
This dataset contains RNA sequencing data for 675 cancer cell lines. RNA libraries were made with the TruSeq RNA Sample Preparation kit (Illumina) according to the manufacturer protocol. The libraries were sequenced on an Illumnia HiSeq 2000
EGAD00001000725 | EGA
GenomicsRNA sequencing and Illumina 2.5M SNP array data collected from 675 commonly used human cancer cell lines.
Tumor-derived cell lines have served as vital models to advance our understanding of oncogene function and therapeutic response1. Although substantial effort has been directed to defining the genomic constitution of cancer cell line panels2–4, the transcriptome – which represents the active program ...
EGAS00001000610 | EGA
GenomicsGenentech gastric cell line sequencing - samples
SNP array data for gastric cancer cell lines
EGAD00010000622 | EGA
Genomicsena-DATASET-Genentech-03-04-2014-21:11:45:639-54 - samples
Exome-seq, RNA-Seq, SNP array profiling of gastric tumor samples.
EGAD00001000815 | EGA
GenomicsExome-seq, RNA-Seq, SNP array profiling of gastric tumor samples and cell lines.
Gastric cancer is the second leading cause of worldwide cancer mortality, yet the underlying genomic alterations remain poorly understood. Here we performed exome and transcriptome sequencing and SNP array assays to characterize 51 primary gastric tumors and 32 cell lines. Meta-analysis of the exome...
EGAS00001000736 | EGA
GenomicsEGAD00000000119
Genotypes from cell lines derived from breast carcinoma tissue
EGAD00000000119 | EGA
GenomicsAssessment of genomic copy number alterations in breast cancer
The aim of this study was to assess genomic copy number alterations in a panel of breast cancer cell lines. These data were used to identify common aberrations associated with breast cancer, and also to identify aberrations associated with response to therapeutic compounds.
EGAS00000000059 | EGA
GenomicsBreast Cancer Cell Line Data Access Committee
Access to data is available by emailing application to the data access committee and will be granted to qualified investigators for appropriate use.
EGAC00000000015 | EGA
Sort   by:  
 Page size